BCM
IHE icon

Beck Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Beck Capital Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,640
Closed -$429K – 154
2015
Q3 		$429K Buy
+8,640
New +$495K 0.3% 63

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Beck Capital Management's IHE Position: Q4 2015 in Review

Beck Capital Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2015, closing a stake of 8,640 shares — an estimated $429K sold.

Beck Capital Management first reported a position in IHE in Q3 2015 and held it in 1 quarter. The position peaked at $429K in Q3 2015. 103 funds tracked by Wall St. Rank hold IHE as of Q4 2015.

  • Beck Capital Management reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
  • Beck Capital Management sold 8,640 iShares US Pharmaceuticals ETF shares in Q4 2015, an estimated $429K.
  • Beck Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q3 2015 and held it in 1 quarter.
  • Beck Capital Management's iShares US Pharmaceuticals ETF position peaked at $429K in Q3 2015.
  • 103 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2015.

Based on Beck Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.